Insider Trading Summary for Y-Mabs Therapeutics, Inc. (YMAB): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
13-Jun-24 9:00 PM View:	11-Jun-24 Grant 0	Gill David N Director		Y-Mabs Therapeutics, Inc. - YMAB	150% 2.33K to 5.83K	0	0	--	--	Show Txns Hide Txns

13-Jun-24 9:01 PM View:	11-Jun-24 Grant 0	Healy James Director		Y-Mabs Therapeutics, Inc. - YMAB	0% 2.22M to 2.23M	0	0	--	--	Show Txns Hide Txns

13-Jun-24 9:00 PM View:	11-Jun-24 Grant 0	Tyagi Ashu Director		Y-Mabs Therapeutics, Inc. - YMAB	150% 2.33K to 5.83K	0	0	--	--	Show Txns Hide Txns

11-Jun-24 7:54 PM View:	10-Jun-24 Sale ($8.66K)	Ber Gerard Director		Y-Mabs Therapeutics, Inc. - YMAB	(31%) 2.33K to 1.61K	0	0	--	--	Show Txns Hide Txns

13-Jun-24 9:02 PM View:	11-Jun-24 Grant 0	Hamill Laura Director		Y-Mabs Therapeutics, Inc. - YMAB	150% 2.33K to 5.83K	0	0	--	--	Show Txns Hide Txns

31-May-24 9:36 PM View:	31-May-24 Option Sale ($378.65K)	Kruse Bo EVP, CFO, Secry & Treas.		Y-Mabs Therapeutics, Inc. - YMAB	9% 192.78K to 210.88K	0	0	--	--	Show Txns Hide Txns

27-Aug-24 5:05 PM View:	26-Aug-24 Market Sale ($73.45K)	Wilms Joris SVP & CHIEF OPERATING OFFICER		Y-Mabs Therapeutics, Inc. - YMAB	72% 17.8K to 30.6K	0	($73.45K) (28%)	--	$14.69	Show Txns Hide Txns

22-Jan-24 5:58 PM View:	18-Jan-24 Grant 0	Lisby Steen SVP & CHIEF SCIENTIFIC OFFICER		Y-Mabs Therapeutics, Inc. - YMAB	100% 17.8K to 35.6K	0	0	--	--	Show Txns Hide Txns

07-Mar-24 4:59 PM View:	05-Mar-24 Private Sale ($27.84K)	Smith Susan Laura SVP & CHIEF COMMERCIAL OFFICER		Y-Mabs Therapeutics, Inc. - YMAB	91% 17.8K to 33.92K	0	0	--	--	Show Txns Hide Txns

30-Aug-24 4:15 PM View:	28-Aug-24 Option Sale ($768.50K)	Lund-Hansen Torben SVP & CHIEF TECHNICAL OFFICER		Y-Mabs Therapeutics, Inc. - YMAB	28% 63.46K to 81.26K	0	0	--	--	Show Txns Hide Txns

07-Mar-24 5:02 PM View:	05-Mar-24 Private Sale ($28.28K)	Rajah Vignesh SVP & CHIEF MEDICAL OFFICER		Y-Mabs Therapeutics, Inc. - YMAB	73% 22.07K to 38.16K	0	0	--	--	Show Txns Hide Txns

14-Feb-24 4:30 PM View:	12-Feb-24 Grant 0	Rossi Michael J President & CEO Director		Y-Mabs Therapeutics, Inc. - YMAB	100% 0 to 35.7K	0	0	--	--	Show Txns Hide Txns

20-Sep-24 4:15 PM View:	19-Sep-24 Option Exercise $100.00K	Gad Thomas Chief Business Officer Director		Y-Mabs Therapeutics, Inc. - YMAB	(45%) 565.53K to 309.21K	0	($1.26M) (17%)	--	$12.97 - $13.47	Show Txns Hide Txns

12-Dec-23 8:27 AM View:	11-Dec-23 Private Purchase $44.23K	Wg Biotech Aps Director		Y-Mabs Therapeutics, Inc. - YMAB	7% 4.28M to 4.56M	0	0	--	--	Show Txns Hide Txns

13-Jun-24 9:02 PM View:	11-Jun-24 Grant 0	Tagliaferri Mary Director		Y-Mabs Therapeutics, Inc. - YMAB	100% 0 to 8.15K	0	0	--	--	Show Txns Hide Txns

13-Jun-24 9:01 PM View:	11-Jun-24 Grant 0	Wedell-Wedellsborg Johan Director 10% Owner		Y-Mabs Therapeutics, Inc. - YMAB	7% 4.28M to 4.57M	0	0	--	--	Show Txns Hide Txns

12-Jul-24 5:29 PM View:	12-Jul-24 Grant 0	Pfreundschuh Peter P. CFO and Treasurer		Y-Mabs Therapeutics, Inc. - YMAB	100% 0 to 46.0K	0	0	--	--	Show Txns Hide Txns

Buy:	0	--
Sell:	($1.34M)	$12.97 - $14.69

Y-Mabs Therapeutics, Inc. (YMAB)

Last Year

23-Nov-23 -- 22-Nov-24

Company Sentiment

Other

Other

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades